Evaluation of a medication monitor-based treatment strategy for drug-sensitive tuberculosis patients in China: study protocol for a cluster randomised controlled trial.

James J LewisXiaoqiu LiuZhiying ZhangBruce V ThomasAnna VassallSedona SweeneyXu CaihongHu DongmeiLi XueGao YongxinShitong HuanJiang ShiwenKatherine L Fielding

Published in: Trials (2018)

This trial was registered with Current Controlled Trials (identifier: ISRCTN35812455 ). Registered on May 19, 2016.

Keyphrases

study protocol
end stage renal disease
newly diagnosed
mycobacterium tuberculosis
healthcare
randomized controlled trial
phase iii
patient reported outcomes
pulmonary tuberculosis
hepatitis c virus
phase ii
open label
smoking cessation
hiv infected
antiretroviral therapy